Vertical excitation energies for DNA and RNA nucleosides are determined with electron structure calculations using the time-dependent density functional theory (TDDFT) method at the B3LYP/6-311++G(d,p) level for nucleoside structures optimized at the same level of theory. The excitation energies and state assignments are verified using B3LYP/aug-cc-pVDZ level calculations. The nature of the first four excited states of the nucleosides are studied and compared with those of isolated bases. The lowest npi* and pipi* transitions in the nucleoside remain localized on the aromatic rings of the base moiety. New low-energy npi* and pisigma* transitions are introduced in the nucleosides as a result of bonding to the ribose and deoxyribose molecules. The effect on the low-lying excited state transitions of the binding to phosphate groups at the 5'- and 3',5'-hydroxyl sites of the uracil ribose nucleoside are also studied. Some implications of these calculations on the de-excitation dynamics of nucleic acids are discussed.
Some members of the naphthalenediol family have been shown in previous work on PC-12 cells to act as effective antioxidants while being relatively nontoxic. In the present work, we extend that study to examine the effect of naphthalenediols on rat primary cortical neurons exposed to AAPH (2,2'-azobis (2-amidinopropane) hydrochloride), a source of peroxyl radicals. Compounds tested included the acetylated forms of 1,2-naphthalenediol, that is, 1,2-ND, as well as 1,4-ND, 2,3-ND, 1,8-ND, and the known highly potent antioxidant (-)-epigallocatechin gallate (EGCG). In cytoxicity studies, cells were exposed to the compounds for 24 h, leading to observed toxicity in the order of 1,4-ND > 1,2 ND >> 2,3-ND approximately EGCG > 1,8-ND. In cytoprotection studies, the desired compounds were incubated with neurons prior to AAPH exposure, and live cell counts were determined by trypan blue and/or MTT assays. Excellent protection, superior to EGCG, was provided by 2,3-ND and 1,8-ND. Additional studies using glutamate as a stressor showed that 1,8-ND had a significant protective effect at concentrations as low as 500 nM. The results can be understood on the basis of the tendency (or lack thereof) to form the corresponding quinone, which in turn depends on whether or not there is a loss of aromaticity in the ring adjacent to the quinone moiety. Thus, certain members of the family of naphthalenediols are quite cytotoxic, whereas others show promise as neuroprotective antioxidants.
Background: Liposomes, vesicular structures in the nano - micrometer range, have been widely studied as drug delivery vehicles. Liposomes can self-assemble in aqueous solutions and are normally comprised of lipids organized in concentric bilayers that enclose an internal aqueous volume, unique in their ability to accommodate a wide variety of therapeutic or diagnostic compounds. Novel liposomal compositions of peptide GAP-107B8, have recently been developed and their inhibitory effect on cell proliferation in cancer cell lines has been studied. Protein kinase B, Akt, has been implicated in certain cancer functions, including cell motility and invasion, hormone independence, chemotherapy and radiation resistance. Abnormalities in Akt are associated with certain breast, pancreatic, colorectal, gastric and ovarian cancers. The present work shows that an important mechanism of action for GAP-107B8 peptide formulations is through modification of protein kinase pathways. Objectives: 1) To optimize GAP-107B8 liposomal formulations, 2) To evaluate the efficacy of GAP-107B8 liposomal formulations towards inhibiting proliferation in ovarian cancer cell lines and 3) To gather information on the inhibitory mechanism of action in ovarian cancer cells. Methods: Optimization of the lipid components in the liposomes including lipid identity and ratio in relation to extent of peptide-liposome association was determined by IEC, liposome size and charge. Cell proliferation was measured in A2780cp and OCC-1 ovarian cancer cell lines with liposomal peptide formulations (24 and 72 hrs). Immunoblotting experiments were executed on cancer cell line lysates treated with peptide to explore inhibitory effects on signaling targets. Results: Peptide association ranged from 80-100% for liposomal formulations prepared with two lipid components in varying ratios (formulation 2A and 2B) as opposed to a single lipid component (formulation 1 - 30%). Treatment of ovarian cancer cells with liposomal formulations 2A, 2B and 3 showed significant inhibition on cell proliferation when compared to control groups. Densitometry results showed a 50% reduction in pAkt levels (relative to Akt levels) when ovarian cells were treated with peptide for 1 hour (similar inhibitory effect found after peptide treatment for 4, 8, 14 and 30 hours). Conclusions: A lipid based delivery system for GAP-107B8 peptide was developed in which lipid ratio played an important role for an enhanced peptide-associated liposomal formulation. Proliferation results indicate that administration of peptides in liposome formulations generally results in improved potency in a time dependent manner. All formulations exhibited greater potency after 72 hrs in comparison to earlier time points. GAP-107B8 was found to be a peptide-based inhibitor of protein kinase B (Akt) with a strong potential for anti-cancer properties. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2907. doi:1538-7445.AM2012-2907
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.